Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity-Reference-Cited by-同舟云学术

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

Published:2010-07-21 Issue:8 Volume:133 Page:2232-2247
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Jones Joanne L.,Anderson Jane M.,Phuah Chia-Ling,Fox Edward J.,Selmaj Krzysztof,Margolin David,Lake Stephen L.,Palmer Jeffrey,Thompson Sara J.,Wilkins Alastair,Webber Daniel J.,Compston D. Alastair,Coles Alasdair J.

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/133/8/2232/16697000/awq176.pdf

Reference49 articles.

1. Image Processing with ImageJ;Abramoff;Biophotonics International,2004

2. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice;Aharoni;Proc Natl Acad Sci USA,2005

3. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ;Aharoni;Proc Natl Acad Sci USA,2003

4. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate;Azoulay;J Neuroimmunol,2005

5. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity;Barouch;FASEB J,2002

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab;Journal of Neuroimmunology;2023-09

2. Biochemical biomarkers for multiple sclerosis;Clinica Chimica Acta;2023-08

3. Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results;Multiple Sclerosis and Related Disorders;2023-05

4. Acquired immunity and Alzheimer's disease;The Journal of Biomedical Research;2023

5. Monoclonal antibodies in multiple sclerosis treatment;Translational Neuroimmunology, Volume 8;2023